John Stagg

Researcher
  • Centre de recherche de Centre hospitalier de L’Université de Montréal
  • Université de Montreal
Home > About Us > Our People > Researcher Bio
  • Bio

Related Research

  • Completed
    Multiple Cancers

    Montreal Cancer Consortium Pilot for the Marathon of Hope Cancer Centres

    Leading researchers, cancer centres and hospitals in Montreal have partnered with The Terry Fox Research Institute to generate new advances in personalized and precision medicine and improve treatment...

    Read More
  • Completed
    Ovarian Cancer

    Immunotherapy network (iTNT): targeting ovarian cancer

    Both around the world and in Canada, teams of researchers are working hard to harness the power of a patient’s own immune system to eradicate cancer through immunotherapy. Hailed now as the four...

    Read More
  • Completed
    Prostate Cancer

    The role of the CD73-adenosinergic pathway in prostate cancer

    New investigator Dr. John Stagg’s recent breakthrough in immunotherapy, or stimulating a patient’s own immune system to destroy tumour cells, could lead to a “promising” new tr...

    Read More

Related News & Events

  • Research Highlight|April 06, 2022

    New study finds that location of immune cells is critical for immunotherapy response

    An innovative new approach highlights the relevance of immune cells’ position within melanoma to inform on a patients’ response to immune therapy.

  • Research Highlight|March 01, 2021

    Turbocharging the killing power of immune cells against cancer

    Creating “super soldiers” of specific white blood cells to boost an anti-tumour response has been shown in a series of elegant experiments by TFRI-fun...

  • Research Highlight|July 01, 2018

    Montreal immunotherapy team studying ways to overcome treatment resistance in patients with melanoma

    Immunologist Dr. John Stagg (Université de Montréal, CR-CHUM) tells us how he and his team will contribute to a Montreal Cancer Consortium (MCC) initi...

  • Research Highlight|July 01, 2018

    Project team in Montreal focuses on reducing side-effects, increasing effectiveness of immune therapies for melanoma patients

    Dr. Watson and his team are researching how the immune system interacts with melanoma, a disease that has been proven to respond favourably to anti-PD...

  • In the Media|June 28, 2018

    Montreal Cancer Consortium created to develop new strategies

    Grouping of seven hospitals and research centres will focus on immunotherapy

  • TFRI News|June 28, 2018

    The Terry Fox Research Institute and Montreal research partners form consortium to provide more personalized treatments for cancer patients in Québec

    Seeking to improve treatments for 18,000 annual cancer patients, leading researchers, cancer centres and hospitals in Montreal and The Terry Fox Resea...

  • TFRI News|August 26, 2015

    Quebec researchers to fight a deadly form of children’s leukemia and to test a new way to kill prostate cancer cells

    Terry Fox spent months in a pediatric ward for his bone cancer. Today, two of three Quebec researchers to receive funding from Terry Fox will pursue n...

  • All News & Events